Table: Daito -Q1 group results

Daito Pharmaceutical

11/10/2017 07:00

Oct 11 (Reuters)-  
             Daito Pharamaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Aug 31, 2017        Aug 31, 2016     May 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             9.68                9.11             40.50     
                 (+6.3 pct)          (+4.3 pct)       (+6.6 pct)   
  Operating        932 mln             929 mln            4.10     
                 (+0.2 pct)          (-4.0 pct)       (+7.0 pct)   
  Recurring        973 mln             967 mln            4.15     
                 (+0.6 pct)          (-4.0 pct)       (+7.0 pct)   
  Net              673 mln             671 mln            2.85     
                 (+0.2 pct)          (-1.0 pct)       (+7.3 pct)   
  EPS             53.80 yen           53.67 yen       227.74 yen   
  Ann Div                             33.00 yen        30.00 yen   
  -Q2 div                             15.00 yen        15.00 yen   
  -Q4 div                             18.00 yen        15.00 yen   
   
  NOTE - Daito Pharamaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T  
  ((Tokyo Headline News Desk +813 6441 1812))